In re HIV Antitrust Litigation
Case Number:
3:19-cv-02573
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Kirkland & Ellis
- Dillingham & Murphy
- Holland & Knight
- Wilson Sonsini
- Hilliard Shadowen
- Zelle LLP
- Ballard Spahr
- Lockridge Grindal
- Pritzker Levine
- Rivero Mestre
- Spector Roseman
- Berry Silberberg
- Wiggin & Dana
- Roberts Law Firm US
- Hagens Berman
- Robins Kaplan
- Faegre Drinker
- Morrison Foerster
- Goodwin Procter
- Nussbaum Law Group
- Kessler Topaz
- Law Offices of Francis O. Scarpulla
- Hausfeld LLP
- Hangley Aronchick
- Gibson Dunn
- Kanner & Whiteley
- Kellogg Hansen
- NastLaw
- Milberg Coleman
- Gibbons PC
- Boies Schiller
- Crowell & Moring
- Radice Law Firm
- Whatley Kallas
- Proskauer Rose
- Sperling Kenny
- Miller Shah
- Duane Morris
- Troutman
- Glancy Prongay
- Cahill Gordon
- Baron & Budd
- Polsinelli PC
- Arnold & Porter
- White & Case
Companies
- Fraternal Order of Police
- BlueCross BlueShield of South Carolina
- MSP Recovery
- Gilead Sciences Inc.
- Amneal Pharmaceuticals Inc.
- Health Care Service Corp.
- Humana Inc.
- Blue Cross Blue Shield Association
- Service Employees International Union
- Viatris Inc.
- Albertsons Cos. Inc.
- Akros Pharma Inc.
- CVS Health Corp.
- Florida Blue
- Aetna Inc.
- Johnson & Johnson Inc.
- Bristol-Myers Squibb Co.
- Zydus Pharmaceuticals Inc.
- Japan Tobacco
- Cipla Ltd.
- Centene Corp.
- The Kroger Co.
- Rite Aid Corp.
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
July 26, 2019
Meet The Top Attys In Gilead's 'No Generics' Antitrust Rumble
Lead lawyers are locked and loaded in an explosive antitrust case accusing Gilead Sciences of pocketing billions of dollars by monopolizing life-saving HIV medicines via a dark conspiracy with fellow drugmakers. Here, Law360 unpacks the allegations and introduces the hot-shot attorneys on both sides of the case.
-
June 25, 2019
Big Pharma's Biggest New Cases Of 2019: Midyear Report
Multibillion-dollar lawsuits targeting major drugmakers emerged with astonishing frequency during the first half of 2019, threatening civil and criminal liability for all manner of alleged wheeling and dealing. Here, Law360 highlights the latest developments and upcoming action in the pharmaceutical world's hottest new cases.
-
May 14, 2019
Gilead Built HIV Drug Empire On 'No Generic' Deals, Suit Says
Despite abysmal scientific innovation, Gilead Sciences Inc. constructed an HIV drug empire worth tens of billions of dollars by devising shadowy deals to block the use of lower-cost generics in combo medicines, according to a proposed class action filed Tuesday.